Clinical evaluation examines respiratory and nutritional status in 5q-spinal muscular atrophy under SMN-directed therapy, highlighting non-motor determinants of long-term prognosis.
Spinal muscular atrophy (SMA) is a progressive hereditary neuromuscular disorder caused predominantly by biallelic pathogenic variants of the SMN1 gene. Deficiency of functional survival motor neuron protein results in progressive degeneration of α-motor neurons, producing symmetrical muscle weakness, muscular atrophy and progressive loss of motor abilities. Although impairment of motor function represents the most evident clinical manifestation of SMA, respiratory, bulbar and nutritional complications are also major determinants of disease burden and long-term prognosis.
No takes yet. Share an insight, caveat, or question.
Kasimova et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: